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Monoclonal antibodies (MAb) were used to show that cultured human amnion epithelial (HuA) cells produce tenascins (Tn) and isoforms of cellular 
fibronectin (cFn). Tn polypeptides of M, 280,000 and 190,000, assembled into extracellular matrix (ECM) but not secreted into the culture medium 
by HuA cells, were electrophoretically similar to those produced by human fibroblasts as revealed with domain-specific MAbs. The results suggested 
that most Fn produced by HuA cells contained the extradomain (ED) A and an oncofetal domain but only a minor fraction EDB. In immunofluo- 
rescence Tn and Fn were seen in different cytoplasmic granules upon monensin-Induced intracellular accumulation. Tn appeared to be deposited 
in the ECM in colocalization with Fn but distinctly slower. The present results show that cultured normal human epithelial cells synthesize Tn 
and three lsoforms of cFn and secrete them by using different cytoplasmic pathways. 
Amnion epithelial cell: Fibronectin; Tenascin; Extracellular matrix; Secretion 
1. INTRODUCTION 
Tn is an extracellular matrix protein sharing sequence 
homology with Fn, epidermal growth factor and fibrin- 
ogen [la] and has been considered to function in vari- 
ous epithelial-mesenchymal interactions during devel- 
opment [2,3,5,6] and to become prominently expressed 
in stromal areas of carcinomas [2,5,7] and healing 
wounds [8]. Immunohistochemical results have attri- 
buted synthesis of Tn to mesenchymal cells [3,5,6] and 
in a recent review epithelial cells were suggested to be 
unable to produce Tn [2]. In recent in situ hybridization 
studies, however, transcripts of Tn were found in sev- 
eral developing epithelial cells [9-l l] some of them con- 
sidered earlier unable to produce Tn (cf. [ 121). 
In the present study we have studied the production 
of Tn and isoforms of cFn in cultures of HuA cells, 
earlier found to produce Fn, laminin and collagens [131. 
The present results show that the HuA cells produce Tn 
and also assemble the protein into extracellular matrix 
together with three distinct, alternatively spliced forms 
of cFn. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
HuA cells were obtained by trypsinization of dissected amniotic 
membranes as described earlier (cf. [14]) and cultured in RPM1 1640 
medium, supplemented with 10% fetal calf serum (FCS; Gibro. Pais- 
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ley, Scotland) and antibiotics. As revealed by IF with cytokeratin 
MAbs the cultures were free of fibroblastic contamination (not shown; 
see [14]). Human embryonal skin fibroblasts were obtained from a 
local source and were cultured as above. In some experiments the cells 
were exposed to monensin (1 PM; Eli Lily, Indianapolis, IN) for 16 
h to prevent cellular secretion [15,16]. For immunoprecipitation exper- 
iments with the MAbs to different Fn isoforms and gelatin-Sepharose 
(Pharmacia, Uppsala, Sweden) affinity chromatography [17] spent 
culture medium of HuA cells was collected. For some experiments the 
serum-free culture media were exposed to (NH&SO, precipitation at 
4°C overnight. Metabolic labeling with [‘5S]methionine (Amersham, 
Buckinghamshire, UK; spec. act. 1,000 mCi/mol) was performed by 
using an overnight incubation (20 pCi/ml) of the cells in MEM me- 
dium, lacking methionine and supplemented with dialysed 1% FCS. 
To produce cell-free ECM, 0.5% sodium desoxycholate (DOC) in 10 
PM Tris-HCI (pH 7.4) was used according to Hedman et al. [18] after 
2 weeks in primary culture or approx. one week after first trypsmiza- 
tion. DOC-matrices of HuA cells and human fibroblasts were then 
subjected to lmmunoblotting and immunoprecipitation experiments. 
2.2. SDS-PAGE, immunoblotting and&orography 
The MAbs lOOEB2 [7], BC-2 [4] and BC-4 [4] against human tenas- 
tin, DHl against EDAcFn [19], BC-1 reacting with EDBcFn [20,21] 
and FDC-6 reacting with an oncofetal epitope in type III connecting 
segment region of cFn [22] have been characterized earlier. For im- 
munoblottmg of DOC-matrices, (NH&SO, precipitates of the culture 
medium, polypeptides bound to gelatin-Sepharose from HuA cells and 
fibroblasts and immunoprecipitates of the HuA cell culture medium 
the samples were boiled in the electrophoresis sample buffer [23] and 
run in 6.5% slab gels. The polypeptides were transferred onto nitrocel- 
lulose accorclmg to Towbin et al. [24] and immunostained with /he 
MAbs by using the indireqt immunoperoxidase method. For lm- 
munoprecipitation of metabolically labeled DOC-matrices the speci- 
mens were dissolved in 1% Triton X-100, 1% DOC and 0.1% SDS in 
50 mM Tris-HCI (pH 7.4). After centrifugation the supernatant was 
exposed to the MAbs and the antigen-antibody complexes were recov- 
ered by using agarose-bound rabbit anti-mouse Igs (Cappel, Organon- 
Teknika, West Chester, PA) and subjected to SDS-PAGE. The sam- 
ples were then subjected to fluorography. 
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Fig. 1. Double IF of HuA cells for Tn (A) and Fn (B) reveals a bright cytoplasmic reactivity for Tn in only some of the cells while all cells prc :sent 
Fn-ret activity. Double IF of monensin-exposed cells revealed Tn in small cytoplasmic granules (C) while Fn was present in larger vacuc ,leS (D). 
In 8 -day cultures both Tn (E) and Fn (F) are seen in ECM fibrils. MAbs reveal in IF EDAcFn (G) and EDBcFn (H). Magnification X6( DO. 
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2.3. Indrect ~mmuno~uorescence (IF) rn~~rosco~y 
For IF the HuA cells were cultured on small coverslips and fixed 
in methanol, cooled to -20°C. Then the cells were reacted with the 
MAbs for 30 min. Fluorescein isothiocyanate (FITC)-coupled sheep 
anti-mouse IgG antiserum (Cappel) was then applied. 
For double IF the cells were first exposed to rabbit anti-Fn antise- 
rum (Dakopatts, Glostrup, Denmark) followed by FITC-coupled 
sheep anti-rabbit IgG (Cappel), then to the Mab lOOEB2 followed by 
tetramethylrhodamine isothiocyanate (TRITC)-coupled sheep anti- 
mouse IgCi (Cappel). The specimens were examined in a Lenz Aristo- 
plan microscope equipped with appropriate filters. 
3. RESULTS 
To study the ECM polypeptides ynthesized by HuA 
cells we first analysed the spent culture medium pro- 
duced by the cells; repeated immunoprecipitation exper- 
iments of the radioactively labeled culture medium or 
immunoblotting experiments of the (NH&SO, precipi- 
tates of the culture medium failed to reveal Tn in HuA 
cell cultures (not shown). However, double im- 
munostaining for Tn (Fig. IA) and Fn (Fig. 1B) of 
freshly seeded HuA cells revealed a cytoplasmic Tn im- 
munoreactivity in codistribution with Fn in many but 
not in all of the cells. Exposure of such cuhures to 
monensin induced an accumulation of Tn into small 
cytoplasmic granules (Fig. IC) while Fn immunoreac- 
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Fig. 2. immunoblotting of SDS-PAGE separated polypeptides of cell- 
free ECM of HuA cells (lanes l-3) and cultured human fibroblasts 
(lanes 4-6). The MAb lOOEB2 reveals polypeptides of IV, 280,000, 
210,000 and 190,000 in both cells (lanes 1 and 4). the MAb BC-4 the 
A4, 280,000 and 190,000 (lanes 2 and 5) while the MAb BC-2 reveals 
only the M, 280,000 and diffuse M, 210.000 bands (lanes 3 and 6). The 
LW~ of the control proteins is indicated on the left. 
Fig. 3. lmmunoprecipitation of cell-free ECMs of metabolically la- 
beled HuA cells with the MAbs lOOEB2 (lane 1) and DHl (lane 2). 
Fluorography reveals polypeptides on M, 280,000 and 190,000 in lane 
1 and a major polypeptide of M, ca. 240,000 in lane 2. The M, of 
control proteins is indicated on the left. 
tivity was seen in distinctly larger vacuoles (Fig. 1 D; see 
also [ 191). In 8 day cultures an emerging codistribution 
of Tn immunoreactivity (Fig. 1E) with extracellular Fn 
fibrils (Fig. IF) was seen. I~unostainings for EDA- 
(Fig. lG), EDB- (Fig. 1H) and one-cFns (not shown) 
revealed that all forms of the protein are deposited into 
ECM fibrils by the HuA cells. 
To study further Tn polypeptides, the cell-free ECM 
of HuA cells were produced by the DOC-treatment. 
Immunoblotting experiments with the MAb lOOEB2 to 
Tn revealed two distinct polypeptides of A4,280,000 and 
190,000 and a diffuse band of ca. IV, 210,000 (Fig. 2, 
lane 1), identical to those found in ECM of cultured 
fibroblasts (Fig. 2, lane 4). Immunoblotting with the 
MAb BC-4, that reacts with an epitope in the aminoter- 
minal part of the molecule, detecting all Tn polypep- 
tides [4], revealed the same major poly~ptide doublet 
(Fig. 2, lane 2) while the MAb BC-2, reacting with an 
epitope within the FN-like repeat which undergoes al- 
ternative splicing in the 280 kDa Tn [4], revealed the M, 
280,000 and diffuse ca. J4, 210,000 bands (Fig. 2, lane 
3). Similar polypeptides were revealed in cell-free ECM 
of human fibroblasts (Fig. 2, lanes 4-6). 
Immunoprecipitation experiments of metabolically 
labeled whole cells (not shown) and DOC-matrices re- 
vealed a doublet of Tn polypeptides of A4,280,000 and 
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190,000 (Fig. 3, lane 1) differing from those precipitated 
by the MAb DHl to EDAcFn (Fig. 3, lane 2). 
Immunoblotting experiments with MAbs to Fn 
isoforms of gelatin-Sepharose-bound polypeptides from 
the culture medium of HuA cells revealed that seem- 
ingly equivalent amounts of EDAcFn (Fig. 4, lane 1) 
and one-cFn (Fig. 4, lane 3) were bound, but signifi- 
cantly less EDBcFn (Fig. 4, lane 2). Further im- 
munoprecipitation experiments of unlabeled HuA cul- 
ture medium subjected to immunoblotting after SDS- 
PAGE with the MAb DHl revealed that the EDAcFn 
immunoprecipitate contained equivalently EDA and 
the oncofetal domain but appeared to lack EDB (Fig. 
5, lanes l-3). 
4. DISCUSSION 
Fn is known to be an adhesive glycoprotein playing 
role in many dynamic phenomena during development, 
wound healing and tumorigenesis [25] while at least in 
vitro Tn appears to interfere with Fn function and may 
have opposing effects also in vivo [2,26,27]. Earlier im- 
munohistochemical and expression studies of Fn 
isoforms, with thusfar unknown functions, suggested 
their differential regulation in cultured cell lines [21,28], 
Fig. 4. Immunoblotting of gelatin-Sepharose-bound polypeptides 
from the culture medium of HuA cells with the MAbs DHI (lane l), 
BC-1 (lane 2) and FDC-6 (lane 3). Note, that similar prominent pol- 
ypeptides of M, 240,000 are seen in lanes 1 and 3 while less reactivity 
for EDBcFn is seen (lane 2). 
Fig. 5. Immunoblotting with cFn MAbs of polypeptides immunopre- 
cipitated from the HuA cell culture medium by the MAb DHl to 
EDAcFn. Immunoreactivities for EDAcFn (lane 1) and one-cFn 
(lane 3) appear similar while no reactivity is seen for EDBcFn (lane 2). 
during development (e.g. [29,30]) and malignant change 
[2,7]. While in situ hybridization studies on developing 
tissues have suggested that also epithelial cells express 
Fn isoforms [30] contrasting results on human epithelial 
tumors have been reported [31,32]. 
Our results with isoform-specific MAbs revealed that 
the HuA cells produced cFn containing EDA, EDB and 
an oncofetal domain. Earlier studies on cultured 
mesenchymal cells have suggested that the percentage 
of cFn molecules from malignant and transformed cells 
would contain higher amounts of EDB and oncofetal 
domain [21,22,28]. The present results suggest that in
HuA cells most cFn molecules contain both EDA and 
oncofetal domain while a minor portion of the mole- 
cules would contain only the EDB. 
The HuA cells appeared to produce Tn polypeptides 
of A4, 280,000- and 190,000-like normal human fibro- 
blasts [7] and were also found in vivo [3,7]. This could 
be shown also with domain-specific MAbs that gave 
identical blotting results with both cell types. Results 
with the MAb BC-4 suggest that the third diffuse M, 
210,000 band represents degradation products which 
have lost the aminoterminal part of the high M, Tn. 
Earlier studies [33] have suggested that the low M, Tn 
polypeptide would mostly participate in ECM assem- 
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bly. Our results show, however, that both in human 
epithelial and fibroblastic cells both Tn polypeptides are 
similarly present in the ECM. 
Interestingly enough, while cFns could be easily de- 
tected in the culture medium and ECM, Tn could only 
be found in the ECM of HuA cells. This would suggest 
that Tn and Fn are differently secreted, Tn in a polar- 
ized manner to the underlying ECM and Fn randomly 
to the medium. This was supported by the finding that 
monensin induced cessation of secretion, and subse- 
quent intracellular accumulation of secretory products 
[ 15,161 revealed cFn and Tn in distinctly different intra- 
cellular vacuoles. Epithelial cells are generally able to 
traffic intracellular protein transport in a polarized way 
(e.g. [34]). Recently, Wang et al. [35] were able to show 
that transforming growth factor j? regulates the polar- 
ized secretion of EDAcFn in tracheal epithelial cells but 
thusfar only endothelial cells have been shown to be 
able to secrete ECM-associated proteins via different 
intracellular pathways [36]. 
Tn production has been mostly attributed to 
mesenchymal cells. These present results show that at- 
tention should be paid also to the function of Tn in 
epithelia. 
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